Cantitate/Preț
Produs

Targeting Trafficking in Drug Development: Handbook of Experimental Pharmacology, cartea 245

Editat de Alfredo Ulloa-Aguirre, Ya-Xiong Tao
en Limba Engleză Hardback – 27 apr 2018
Cellular trafficking is only recently identified as a site for therapeutic intervention. This book provides up to date information on the mechanism for exploiting this area for drug development as well as a clear understanding of the individual components of cellular trafficking. The authors are experts in their areas and the book features tables and figures that enable comparison and clear understanding.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 154674 lei  3-5 săpt.
  Springer International Publishing – 15 feb 2019 154674 lei  3-5 săpt.
Hardback (1) 203697 lei  3-5 săpt.
  Springer International Publishing – 27 apr 2018 203697 lei  3-5 săpt.

Din seria Handbook of Experimental Pharmacology

Preț: 203697 lei

Preț vechi: 214417 lei
-5% Nou

Puncte Express: 3055

Preț estimativ în valută:
38985 41127$ 32488£

Carte disponibilă

Livrare economică 12-26 decembrie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319741635
ISBN-10: 3319741632
Pagini: 392
Ilustrații: VIII, 425 p. 57 illus., 55 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.76 kg
Ediția:1st ed. 2018
Editura: Springer International Publishing
Colecția Springer
Seria Handbook of Experimental Pharmacology

Locul publicării:Cham, Switzerland

Cuprins

1. Intracellular trafficking of gonadotropin receptors in health and disease.- 2. Investigating internalization and intracellular trafficking of GPCRs.- 3. Pharmacological chaperones as potential therapeutic strategies for misfolded mutant vasopressin receptors.- 4. Targeting of disordered proteins by small molecules in neurodegenerative diseases.- 5. Pharmacoperones for misfolded gonadotropin receptors.- 6. Pharmacological chaperones: Beyond conformational disorders.- 7. Natural (and unnatural) small molecules as pharmacological chaperones and inhibitors in cancer.- 8. Heritable skeletal disorders arising from defects in processing and transport of Type I procollagen from the ER: perspectives on possible therapeutic approaches.- 9. Conserved oligomeric Golgi and neuronal vesicular trafficking.- 10. SLC6 transporter folding diseases and pharmacochaperoning.- 11. The molecular physiopathogenesis of islet amyloidosis.- 12. Folding defects leading to primary hyperoxaluria.- 13. Potentialpharmacological chaperones for cystathionine beta-synthase-deficient homocystinuria.    

Caracteristici

Broadens your understanding of therapeutic intervention at the level of trafficking Suitable for both experts needing information on recent advances and new researchers in the area Written by leading authorities in the field of protein trafficking